A UCSF-led team has discovered at least one key reason why blood stem cells are susceptible to developing the genetic mutations that can lead to adult leukemia.
August 16, 2010
August 09, 2010
A UCSF-led team has discovered a direct link between an inherited genetic mutation, a set of developmental abnormalities and a rare form of childhood leukemia called juvenile myelomonocytic leukemia, or JMML.
August 05, 2010
Surgery for localized prostate cancer offers a significantly higher survival rate than either external-beam radiation or hormonal therapies, according to a new study led by researchers at UCSF.
July 02, 2010
Antibiotic-resistant Staph infection is not the only emerging bacterial threat. Now a different bug -- Clostridium difficile -- is gaining strength.
June 11, 2010
It is well-known that vitamin D is essential for strong and healthy bones. However, in an article in the online “In Press” section of “Trends in Endocrinology and Metabolism,” a San Francisco VA Medical Center physician reviews recent scientific literature suggesting that the vitamin may also play a role in preventing cancer, fighting infection, and controlling or preventing auto-immune disease.
June 07, 2010
A single dose of radiation administered during surgery is as effective for patients with early forms of breast cancer as standard radiation therapy that can take as long as six weeks, according to new research findings.
June 02, 2010
The UCSF community is invited to a symposium to address unsolved health problems, such as cancer and malaria, as a tribute to the 11-year tenure of Mike Bishop, MD, former chancellor of UCSF.
May 25, 2010
The UCSF Helen Diller Family Comprehensive Cancer Center hosted an afternoon event on the Mission Bay campus on May 12 to showcase recent progress and current research directions in the fight against cancer.
April 28, 2010
For the first time, scientists have discovered a way to predict whether women with ductal carcinoma in situ (DCIS) – the most common form of non-invasive breast cancer – are at risk of developing more invasive tumors in later years.
March 18, 2010
Taking an innovative path toward personalized medicine, scientists for the first time will be able to eliminate – at an early point in a clinical trial — experimental drugs that show poor efficacy, dramatically shortening the time it takes to get the right medication to the right patient with breast cancer.